Patent · US Active

Aminostatin derivatives for the treatment of arthrosis

US9345742B2 · kind B2 · utility

0Cited by

8References

3Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Markus Klein · Weiterstadt, DE
Christos Tsaklakidis · Weinheim, DE
Hans Guehring · Eltville am Rhein, DE
Brigitta Leuthner · Darmstadt, DE

Key dates

Filing date	Jan 9, 2012
Grant date	May 24, 2016
Priority date	—
Expiry date	Jan 9, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of the formula (I) and in particular medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.